Epidemiology of hepatitis A and vaccination policy

QR Code

Epidemiology of hepatitis A and vaccination policy

Hepatitis A (HA) is an acute infectious disease of the liver caused by the hepatitis A virus (HAV). HA disease incidence rate is closely linked to the social and economical development. The results of seroepidemiologic studies show that the prevalence of anti-HAV antibodies in population ranges from...

Full description

Saved in:

Bibliographic Details
Main Authors:	I. N. Indikova, V. A. Shevtsov, A. R. Volgin, Yu. V. Olefir, V. A. Merkulov, V. P. Bondarev
Format:	Article
Language:	Russian
Published:	Ministry of Health of the Russian Federation. Federal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products» 2018-02-01
Series:	Биопрепараты: Профилактика, диагностика, лечение
Subjects:	вирусный гепатит а вакцинопрофилактика инактивированные вакцины иммуногенность hepatitis a virus vaccination inactivated vaccines immunogenicity
Online Access:	https://www.biopreparations.ru/jour/article/view/27
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

The Study in Animal Models of Local Action, Acute and Chronic Toxicity of Inactivated Influenza Vaccine Ultriks in Syringe
by: O. G. Kurskaya, et al.
Published: (2015-06-01)

Vaccinoprophylaxis of Hepatitis B N.A
by: N. A. Ozeretskovsky, et al.
Published: (2015-04-01)

Experimental Approaches to the Development of Inactivated Poliovirus Vaccine Based on Sabin Strains
by: A. P. Ivanov, et al.
Published: (2016-08-01)

Epidemiological and Immunological Efficacy of Health Workers Vaccination against Hepatitis B
by: V. G. Akimkin, et al.
Published: (2017-08-01)

Prophylaxis of Acute Enteric Infections and Viral Hepatitis A under Emergency Situation in the Territory of the Amur Region
by: T. V. Korita, et al.
Published: (2014-03-01)

The Investigation of the Prospects for Using NS4A Antigen of Hepatitis C Virus for the Development of Recombinant Mosaic Vaccines with Self-Adjuvant Properties
by: V. V. Koupriyanov, et al.
Published: (2017-02-01)

Immunologic peculiarities of acute viral hepatitis B in dependence on infectious process outcomes
by: K. I. Chouikova, et al.
Published: (2006-09-01)

Current Meningococcal Vaccines: Advantages and Disadvantages and New Challenges
by: N. N. Kostyukova, et al.
Published: (2016-08-01)

Strengthening the Effectiveness of the Candidate Influenza Vaccine by Combining Conserved Sequences of Hemagglutinin and M2 protein
by: L. M. Tsybalova, et al.
Published: (2017-06-01)

Study on the Impacts of Haemoglobin Genotype on Hepatitis B vaccine Response among Vaccinated Individuals within Bauchi State, Nigeria
by: Thomas, K. M., et al.
Published: (2025-06-01)

<i>Haemophilus</i><i> influenzae</i> type <i>b</i>. Incidence rate and preventive vaccination
by: M. V. Abramtseva, et al.
Published: (2018-02-01)

Prospects of Using Domestic Hepatitis B Vaccines to Ensure Sanitary and Epidemiological Well-Being
by: I. V. Fel'dblyum
Published: (2017-08-01)

Experimental study of the protective effect of tuberculosis vaccines
by: D. T. Levy, et al.
Published: (2018-02-01)

Meningococcal disease. Polysaccharide meningococcal vaccines. The historical aspects and the current state of vaccine development. Report 2
by: M. V. Abramtseva, et al.
Published: (2018-02-01)

Immunoprophylaxis of Infectious Diseases in Russia: Condition and Perspective of Improvement
by: N. I. Brira, et al.
Published: (2017-04-01)

The analysis of a long-term experience of studying inactivated cell-culture vaccines for preventing tick-borne encephalitis of domestic and foreign manufacture in terms of specific activity (immunogenicity)
by: M. S. Vorobieva, et al.
Published: (2018-02-01)

Promising opportunities to improve polio vaccines
by: E. E. Evreinova, et al.
Published: (2022-07-01)

Assessment of Reactogenicity and Immunogenicity of the Quadrivalent Live Attenuated Influenza Vaccine
by: D. A. Lioznov, et al.
Published: (2018-06-01)

Vaccines with adjuvants. Preclinical studies
by: Zh. I. Avdeeva, et al.
Published: (2018-02-01)

Vaccination contribute to the development of personal and herd immunity
by: N. V. Medunitsyn, et al.
Published: (2018-02-01)

Vaccine interchangeability: problems and prospects
by: N. A. Gavrilova, et al.
Published: (2021-10-01)

Comparative Analysis of Approaches to Assess the Quality of Inactivated Influenza Vaccines: Regulatory Requirements in the Russian Federation and European Union
by: L. M. Khantimirova, et al.
Published: (2021-01-01)

Efficacy and Safety of Cholera Vaccines
by: A. A. Goryaev, et al.
Published: (2018-03-01)

Experience in Organizing in Metropolis Mobile Immunization to Vaccinate Adults against Flu
by: O. V. Filippov, et al.
Published: (2017-08-01)

Rotavirus Epidemiology and Vaccination Tactics
by: V. P. Bondarev, et al.
Published: (2019-06-01)

Assessment of the humoral immune response in children after immunization with different types of inactivated influenza vaccines in the 2019-2020 season
by: Zh. V. Buzitskaya, et al.
Published: (2023-06-01)

Comparative Immunogenicity Evaluation of Characterized Chitosan-Based and Other Adjuvants for Inactivated Influenza Vaccines
by: L. M. Khantimirova, et al.
Published: (2016-02-01)

The Effectiveness of Vaccination in Sickly Children with Disorders of the Central Nervous System
by: S. P. Kaplina, et al.
Published: (2015-10-01)

Immunogenicity and Clinical Efficacy Combined Vaccine against Diphtheria, Tetanus and Hepatitis B in Patients with Chronic Obstructive Pulmonary Disease
by: M. P. Kostinov, et al.
Published: (2017-08-01)

Hepatitis B vaccines in clinical practice /
Published: (1993)

Immunogenicity analysis of a composition of inactivated human rotavirus A strains in mice following immunisation
by: M. V. Kovrizhko, et al.
Published: (2024-12-01)

Condition and Prospects of Development of Vaccines for Specific Prevention of Enterovirus (Nonpolio) Infection
by: E. A. Yagovkin, et al.
Published: (2016-08-01)

Immunogenicity and Reactogenicity of Francisella tularensis Strain 15/23-1 recA - the Candidate for a New Live Tularemia Vaccine
by: A. N. Mokrievich, et al.
Published: (2015-12-01)

Update of influenza vaccine strains in Europe. Quality issues
by: A. A. Soldatov, et al.
Published: (2018-02-01)

The immunogenicity and safety of an inactivated quadrivalent influenza vaccine and a 23-valent pneumococcal polysaccharide vaccine in individuals with chronic diseases
by: Wanqin Tang, et al.
Published: (2025-08-01)

Preventive Vaccination against Poliomyelitis: Modern View
by: E. V. Karpova, et al.
Published: (2018-12-01)

The present vaccinoprophilaxis of tick-borne encephalitis and vaccines for its provision
by: M. S. Vorob’Eva, et al.
Published: (2006-12-01)

Present Epidemical Situation of Viral Hepatitides and Tuberculosis Morbidity Rates in Moscow
by: A. A. Asratyan, et al.
Published: (2015-06-01)

Phosphatase Activity in Chemical Cholera Vaccine and its Components
by: O. V. Gromova, et al.
Published: (2012-06-01)

Historical and Modern Views on the Problem of Specific Plague Prophylaxis
by: S. A. Bugorkova, et al.
Published: (2013-09-01)